Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma

Background: MicroRNA (abbreviated miRNA)-based treatment holds great promise for application as clinical antitumor therapy, but good carriers for delivery of the miRNA drug are lacking. Exosomes secreted by mesenchymal stem cells (MSCs) have proved to be safe, and exogenously modified exosomes may p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahati, Shaya, Fu, Xiangjun, Ma, Xuexian, Zhang, Hua, Xiao, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450326/
https://www.ncbi.nlm.nih.gov/pubmed/34552961
http://dx.doi.org/10.3389/fmolb.2021.738219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450326/
https://www.ncbi.nlm.nih.gov/pubmed/34552961
http://dx.doi.org/10.3389/fmolb.2021.738219

Ejemplares similares